4D Molecular Therapeutics (FDMT) Return on Capital Employed [ROCE] (2021 - 2026)
4D Molecular Therapeutics (FDMT) posted Return on Capital Employed [ROCE] of -43.31% for Q2 2026, up 4.58 percentage points from -47.90% a year earlier but down 7.14 percentage points from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, 4D Molecular Therapeutics' Return on Capital Employed [ROCE] came in at -30.71%, up 13.91 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +5.49 percentage points (FY2020 to FY2025).
- In prior years, 4D Molecular Therapeutics' Return on Capital Employed [ROCE] was -44.62% in FY2024 (-4.58 pp), -40.04% in FY2023 (-2.34 pp), -37.69% in FY2022 (-14.27 pp) and -23.42% in FY2021 (+12.78 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of -55.96% in Q3 2025 to a high of -21.67% in Q2 2024 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of -7.29 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 21.26 percentage points; the weakest was Q3 2025, with a drop of 27.06 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -36.17% (Q1 2026), -35.35% (Q4 2025) and -55.96% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | 4D Molecular Therapeutics | 972.56 Mn | -487.38 Mn | - | -43.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.31% |
| Mar 31, 2026 | -36.17% |
| Dec 31, 2025 | -35.35% |
| Sep 30, 2025 | -55.96% |
| Jun 30, 2025 | -47.90% |
| Mar 31, 2025 | -39.78% |
| Dec 31, 2024 | -33.96% |
| Sep 30, 2024 | -28.90% |
| Jun 30, 2024 | -21.67% |
| Mar 31, 2024 | -25.81% |
| Dec 31, 2023 | -34.02% |
| Sep 30, 2023 | -30.96% |
| Jun 30, 2023 | -41.28% |
| Mar 31, 2023 | -47.07% |
| Dec 31, 2022 | -43.10% |
| Sep 30, 2022 | -38.16% |
| Jun 30, 2022 | -34.13% |
| Mar 31, 2022 | -24.89% |
| Dec 31, 2021 | -25.41% |
| Sep 30, 2021 | -28.34% |
API Access
4D Molecular Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();